Long Term: Veralto Corporation
Explore this signal
Long Term at a glance
Short reader summary
Water-quality recurring revenue is a conditional thesis, not an automatic benefit from PFAS regulation. US$118.25 is the frozen Friday close; acquisitions and a premium multiple require demonstrated cash returns.
Exact asset or item
Veralto common shares
Asset type
Listed investment
Reference price
118.25
Currency code
USD
Price observed at
2026-11-13T16:00:00-05:00
What this number represents
Tracking price
What remains unproven
No trade. Regulatory changes remain proposals; acquisition synergies and future cash returns are unproved.
Exact asset or item
Exact asset or item
Veralto common shares
Asset type
Listed investment
Ticker
VLTO
Exchange
NYSE
How to identify this exact asset
NYSE VLTO common shares; USD per share; main research horizon three years.
Price and what it means
Entry or reference price
118.25
Currency code
USD
Price observed at
2026-11-13T16:00:00-05:00
What this number represents
Tracking price
Price evidence status
Verified
Price source
Publisher: Stock Analysis
Original language: English
Reading access: partial
Underlying origin: VLTO-S7
published date precision: day
retrieved date precision: day
Source publication date 2026-11-13
Source retrieval date 2026-11-15
Matching price source ID
VLTO-S7
Purchase, sale and realised profit
Permanent original entry: USD 118.25 per share, 13 November 2026 at 16:00 EST, Stock Analysis history page (full link in Sources). Latest checked price: same USD 118.25 Friday regular-session quote; no newer qualified regular-session update. Price change: 0.00% measured against the identical initial frozen observation, NOT realised profit. Estimated result after stated costs: NOT ASSESSABLE; commissions, FX, custody and individual tax not priced, and no shares bought. Actually sold? NO, no trade. Forecast status: NOT YET DUE. Initial full hypothesis and downside/upside cases remain frozen in this issue; later contradictory evidence must be added as a separately dated update rather than rewriting this baseline. Next review: 15 May 2027 (interim event checks described above).
The developments we connected
Separate development
What changed
Reported Q3 growth and cash
Date of the development
Evidence status
Observed
What the evidence shows
Q3 sales US$1.509bn, core growth5.1%, operating cashUS$323m and non-GAAP FCFUS$304m reported; not a shareholder return.
Source IDs
- VLTO-S1
What changed
Potential compliance delay
Date of the development
Evidence status
Observed
What the evidence shows
EPA proposed optional two-year extension to2031 for PFOA/PFOS compliance; proposal is not final rule.
Source IDs
- VLTO-S4
Emerging insight
REPORT A - 18 May 2026, US EPA: proposed compliance changes may spread drinking-water upgrades over more years. REPORT B - 2026 Veralto SEC filings: the company completed water-monitoring and disinfection-related acquisitions; integration and price paid are real, but synergies are not cash. REPORT C - 29 October 2026 Veralto results: water-quality demand and quarterly operating cash were reported. Hidden link: a utility installing testing and treatment equipment may later buy consumables, parts and cloud tools, creating follow-on revenue if customer retention is proven.
How this exact asset could benefit
Hach and associated water-quality businesses supply measuring tools, reagents and service; treatment businesses support water-system upgrades. The shareholder benefit is not a raw headline about PFAS regulation: it is recurring paid sales, retained margins and stronger cash flow per share after acquisition integration and spending. Proven: reported revenue, operating cash and completed acquisitions. Unproven: exact PFAS-specific sales contribution, future utility budgets, acquisition synergies and end-customer compliance urgency.
Who could benefit
Who
Veralto and conditionally shareholders
How they could benefit
Repeat consumables, service and software revenue must exceed integration, financing and capital costs.
Evidence status
Still unproven
What we observed
29 October 2026, United States: Veralto reported Q3 sales about USD 1.509 billion, up 7.5%, core sales up 5.1%, operating cash flow USD 323 million, and free cash flow USD 304 million. Its 2026 filings document the completed acquisition of In-Situ in January, GlobalVision in April and Cleanwater1 in October, with acquisition cash expenditure and integration risk. On 18 May 2026, EPA proposed extending PFOA and PFOS compliance deadlines; separately it proposed changes affecting four other PFAS substances. A proposal is not yet a final relaxation, but it challenges the idea that regulation forces immediate orders.
What remains unproven
PFAS-specific revenue, retention, acquisition synergies, final rule timing, future municipal budgets and fair value unverified.
What to check before acting
Entry conditions
13 November close USD 118.25, implied market capitalisation near USD 28.75 billion and trailing P/E roughly 29.2 per Stock Analysis. A quality premium means even modest growth could already be priced in. The dossier does not assume an EPA proposal is final or that each acquired installed device guarantees a subscription. Track growth after excluding acquisition contributions, organic recurring revenue, goodwill and cash after integration spending.
Possible upside
Acquisitions deliver retained customers, repeat sales and higher per-share cash.
Possible downside
Compliance delays and poor acquired-business cash returns trigger valuation compression.
Price or return range method
Downside: a regulatory timetable is relaxed and purchased businesses fail to earn their cost; stock de-rates. Base: utility upkeep supports modest repeat sales while integration costs offset early gains. Upside: acquisitions produce measurable, high-retention water-monitoring and treatment revenue. Future-price ranges NOT ESTIMATED: a reliable long-term unit-economics model for the acquisitions and final rule timing is unavailable.
Costs and fees
Brokerage, exchange fees, FX, custody and personal taxes vary and have not been individually priced. No trades or realised gains.
How hard it may be to sell
NYSE shares via eligible brokerage during market hours; price, spread, settlement and access not guaranteed.
Key risks
Main risk: the water-regulation story is over-generalised: PFAS proposals can slow purchases, customers face public-budget constraints, and acquisition goodwill could be written down. Another explanation: near-term reported growth came from bought sales rather than new underlying demand. Disproof: by May 2027, the reported organic Water Quality growth has weakened while integration spending has increased and no retention or cash benefit can be shown. These are listed shares, so a reader may generally sell through an eligible brokerage during exchange hours, but price, spread, trading access and settlement are not guaranteed. Fees may include brokerage commissions, exchange or regulatory fees, foreign-exchange spread and personal taxes depending on residence; exact amounts were not independently verified. The share price can lose substantial value, even when the company grows. No margin borrowing or executed trades are assumed.
What an ordinary reader can do next
Read the actual EPA rule-making page and latest Veralto SEC cash-flow statement. Mark rules proposed/final separately. Track organic growth versus acquisition revenue and estimate acquisition cash returns without inventing synergies. Reassess if regulators change deadlines or per-share free cash flow stagnates.
Original forecast record
Original forecast in full
Long Term: Veralto Corporation Category: Shares Exact asset: NYSE: VLTO | common shares Country and currency: United States, USD Published: 15 November 2026, 18:53 SGT Information cutoff: 15 November 2026, 18:53 SGT Main time horizon: 3 years Current position: CONDITIONAL OPPORTUNITY
The opportunity in one sentence
Water quality sensors and treatment systems may turn changing regulations into repeat consumables and software revenue, but compliance delays could weaken demand.
Entry price and date
Reference entry price: USD 118.25 per common share. Price observed: 13 November 2026, 16:00 EST (14 November 2026, 05:00 SGT). Market: NYSE: VLTO. Source/market: Stock Analysis historical regular-session US-listed market close. Type: historical market quote, not an ask, executable order or completed sale. Ordinary reader access: subject to brokerage and market eligibility, spreads, foreign exchange and fees. Entry note: tracking price ONLY, NOT an actual purchase. There is no executable 15 November Sunday quote.
What changed?
29 October 2026, United States: Veralto reported Q3 sales about USD 1.509 billion, up 7.5%, core sales up 5.1%, operating cash flow USD 323 million, and free cash flow USD 304 million. Its 2026 filings document the completed acquisition of In-Situ in January, GlobalVision in April and Cleanwater1 in October, with acquisition cash expenditure and integration risk. On 18 May 2026, EPA proposed extending PFOA and PFOS compliance deadlines; separately it proposed changes affecting four other PFAS substances. A proposal is not yet a final relaxation, but it challenges the idea that regulation forces immediate orders.
View chart values
| Step | Kind | Value |
|---|---|---|
| Operating cash | start | 323 |
| Capital expenditure | change | -19 |
| Free cash flow | total | 304 |
- Veralto Q3 earnings exhibit · 2026-10-29
The connection most people may miss
REPORT A - 18 May 2026, US EPA: proposed compliance changes may spread drinking-water upgrades over more years. REPORT B - 2026 Veralto SEC filings: the company completed water-monitoring and disinfection-related acquisitions; integration and price paid are real, but synergies are not cash. REPORT C - 29 October 2026 Veralto results: water-quality demand and quarterly operating cash were reported. Hidden link: a utility installing testing and treatment equipment may later buy consumables, parts and cloud tools, creating follow-on revenue if customer retention is proven.
How this could make money
Hach and associated water-quality businesses supply measuring tools, reagents and service; treatment businesses support water-system upgrades. The shareholder benefit is not a raw headline about PFAS regulation: it is recurring paid sales, retained margins and stronger cash flow per share after acquisition integration and spending. Proven: reported revenue, operating cash and completed acquisitions. Unproven: exact PFAS-specific sales contribution, future utility budgets, acquisition synergies and end-customer compliance urgency.
Why the entry price matters
13 November close USD 118.25, implied market capitalisation near USD 28.75 billion and trailing P/E roughly 29.2 per Stock Analysis. A quality premium means even modest growth could already be priced in. The dossier does not assume an EPA proposal is final or that each acquired installed device guarantees a subscription. Track growth after excluding acquisition contributions, organic recurring revenue, goodwill and cash after integration spending.
Time-horizon forecast
Horizon Review date What we expect / need to see What would challenge it 6 months 15 May 2027 Water Quality segment organic sales and service mix in the next filing Water demand stalls despite acquisition revenue 1 year 15 November 2027 Evidence of first integrated In-Situ/Cleanwater1 cross-sales rather than promises No evidence of integrated customer wins 2 years 15 November 2028 Final EPA rule status and dated municipal procurement decisions EPA extends compliance and municipalities delay orders 3 years 15 November 2029 Recurring consumable or service revenue and customer retention disclosed Lower gross margin or elevated inventory 4 years 15 November 2030 Return on purchased businesses versus acquisition cost and goodwill Cash returns on acquisitions below the cost of capital 5 years 15 November 2031 Per-share free cash flow after acquisitions, debt and buybacks Premium earnings valuation compresses despite stable results
- 15 May 2027Organic Water Quality growth and service mix
- 15 November 2027Integrated customer wins
- 15 November 2028Final rules and municipal procurement
- 15 November 2029Recurring revenue and retention
- 15 November 2030Acquisition cash returns versus cost
- 15 November 2031Free cash flow per share
- Original supplied LongTerm dossier · 2026-11-15
Possible price outcomes
Downside: a regulatory timetable is relaxed and purchased businesses fail to earn their cost; stock de-rates. Base: utility upkeep supports modest repeat sales while integration costs offset early gains. Upside: acquisitions produce measurable, high-retention water-monitoring and treatment revenue. Future-price ranges NOT ESTIMATED: a reliable long-term unit-economics model for the acquisitions and final rule timing is unavailable.
What could go wrong?
Main risk: the water-regulation story is over-generalised: PFAS proposals can slow purchases, customers face public-budget constraints, and acquisition goodwill could be written down. Another explanation: near-term reported growth came from bought sales rather than new underlying demand. Disproof: by May 2027, the reported organic Water Quality growth has weakened while integration spending has increased and no retention or cash benefit can be shown. These are listed shares, so a reader may generally sell through an eligible brokerage during exchange hours, but price, spread, trading access and settlement are not guaranteed. Fees may include brokerage commissions, exchange or regulatory fees, foreign-exchange spread and personal taxes depending on residence; exact amounts were not independently verified. The share price can lose substantial value, even when the company grows. No margin borrowing or executed trades are assumed.
What an ordinary person can do
Read the actual EPA rule-making page and latest Veralto SEC cash-flow statement. Mark rules proposed/final separately. Track organic growth versus acquisition revenue and estimate acquisition cash returns without inventing synergies. Reassess if regulators change deadlines or per-share free cash flow stagnates.
What happens next?
Review by 15 February 2027 for post-Q3 operating-cash conversion and any EPA final compliance dates. EPA actions are not predicted to occur by that day; the date is an OTR monitoring checkpoint.
OTR tracking record
Permanent original entry: USD 118.25 per share, 13 November 2026 at 16:00 EST, Stock Analysis history page (full link in Sources). Latest checked price: same USD 118.25 Friday regular-session quote; no newer qualified regular-session update. Price change: 0.00% measured against the identical initial frozen observation, NOT realised profit. Estimated result after stated costs: NOT ASSESSABLE; commissions, FX, custody and individual tax not priced, and no shares bought. Actually sold? NO, no trade. Forecast status: NOT YET DUE. Initial full hypothesis and downside/upside cases remain frozen in this issue; later contradictory evidence must be added as a separately dated update rather than rewriting this baseline. Next review: 15 May 2027 (interim event checks described above).
Publication verification and valuation sensitivity
Original research time is 18:53 SGT on 15 November 2026, not the later website publication time. All eight original source links were reopened in this check. The SEC exhibit confirms Q3 operating cash of US$323m, capex US$19m and non-GAAP FCF US$304m; trailing-four-quarter FCF is US$1,093m, not four times the latest quarter. At approximate US$28.75bn equity value this implies a 3.8% historical FCF yield before investor costs; it is not cash available for dividends or a prospective return. The 2 October balance sheet reports debt US$2,920m and cash US$1,785m, implying US$1,135m net debt before subsequent acquisition effects. Cleanwater1 closed 5 October for US$465m subject to adjustments; these balance-sheet numbers therefore precede closing. No final EPA extension rule was found; the agency still describes proposals.
The original dossier declined price forecasts. The following additional three-year sensitivity is an illustrative assumption grid, not a replacement forecast or estimated fair value: start with secondary-provider trailing EPS US$4.05; compound annual EPS at -2%, 5%, 10%, then apply terminal P/E 20, 25, 30 respectively. This produces US$76.24, US$117.21 and US$161.72 per share. These are not probabilities or price targets. Inputs are deliberately variable, exclude dividends, taxes and fees, and do not assume acquisition synergies. Regulatory timing, dilution, integration, debt and business mix could invalidate them. A DCF was not manufactured: acquisition-specific cash flows and cost-of-capital estimates are not verified.
| Assumption case | Annual EPS growth | Terminal P/E | Illustrative USD/share |
|---|---|---|---|
| Downside | -2% | 20 | 76.24 |
| Middle sensitivity | 5% | 25 | 117.21 |
| Upside | 10% | 30 | 161.72 |
- Trailing EPS input, Stock Analysis · 2026-11-13
- Publisher hypothetical sensitivity assumptions · 2026-11-15
Sources
The per-entry check timestamp below is the research-session audit check, not a confirmed native web-server response completion. "Indexed" items may not have been readable in full; no unverified link counts as proof of a completed contract or cash receipt. 1. Veralto Q3 2026 Earnings Exhibit 99.1 | US SEC / Veralto | Original: 29 Oct 2026 | Source country/language: United States / English https://www.sec.gov/Archives/edgar/data/1967680/000196768026000047/vlto-20261029xex991.htm Audited: 15 November 2026, 18:53 SGT | Supports: Q3 sales, organic growth, cash and free cash flow | Access: Indexed SEC exhibit; provider open restricted 2. Veralto Q3 2026 Form 10-Q | US SEC / Veralto | Original: Oct 2026 | Source country/language: United States / English https://www.sec.gov/Archives/edgar/data/1967680/000196768026000048/vlto-20261002.htm Audited: 15 November 2026, 18:53 SGT | Supports: Acquisition cost, dates, regulatory and integration disclosures | Access: Indexed source / direct link checked 3. Veralto Q2 2026 Form 10-Q | US SEC / Veralto | Original: 2026 Q2 | Source country/language: United States / English https://www.sec.gov/Archives/edgar/data/1967680/000196768026000044/vlto-20260703.htm Audited: 15 November 2026, 18:53 SGT | Supports: Earlier acquisition accounting and cash comparison | Access: Indexed source / direct link checked 4. Proposed PFOA and PFOS Compliance Extension Rule | US EPA | Original: 18 May 2026 | Source country/language: United States / English https://www.epa.gov/sdwa/proposed-pfoa-and-pfos-compliance-extension-rule Audited: 15 November 2026, 18:53 SGT | Supports: Counter-case on timing of mandated upgrades | Access: Indexed source / direct link checked 5. Proposed PFAS Rescission Rule | US EPA | Original: 18 May 2026 | Source country/language: United States / English https://www.epa.gov/sdwa/proposed-pfas-rescission-rule Audited: 15 November 2026, 18:53 SGT | Supports: Regulatory uncertainty for several PFAS requirements | Access: Indexed source / direct link checked 6. Key EPA Actions to Address PFAS | US EPA | Original: 2026 ongoing updates | Source country/language: United States / English https://www.epa.gov/pfas/key-epa-actions-address-pfas Audited: 15 November 2026, 18:53 SGT | Supports: Policy context; check proposal versus final action | Access: Indexed source / direct link checked 7. VLTO historical share prices | Stock Analysis | Original: 13 Nov 2026 16:00 EST | Source country/language: United States / English https://stockanalysis.com/stocks/vlto/history/ Audited: 15 November 2026, 18:53 SGT | Supports: Verified USD 118.25 historical closing quote | Access: Indexed source / direct link checked 8. VLTO market valuation and P/E | Stock Analysis | Original: 13 Nov 2026 | Source country/language: United States / English https://stockanalysis.com/stocks/vlto/ Audited: 15 November 2026, 18:53 SGT | Supports: Indicative valuation, sector and earnings multiple | Access: Indexed source / direct link checked 9. Cleanwater1 subsequent-event disclosure | SEC / Veralto | Acquisition 5 October 2026 https://www.sec.gov/Archives/edgar/data/1967680/000196768026000048/R21.htm Supports: Completed acquisition and price, not completed synergies.
Original forecast date and time
2026-11-15T18:53:00+08:00
Forecasts and review dates
6 months
Review date
2027-05-15
Original forecast
Water Quality segment organic sales and service mix in the next filing
What to measure
Water Quality segment organic sales and service mix in the next filing
What must happen
Conditional review: Water Quality segment organic sales and service mix in the next filing
What would challenge the forecast
Water demand stalls despite acquisition revenue
Current outcome
Not yet due
1 year
Review date
2027-11-15
Original forecast
Evidence of first integrated In-Situ/Cleanwater1 cross-sales rather than promises
What to measure
Evidence of first integrated In-Situ/Cleanwater1 cross-sales rather than promises
What must happen
Conditional review: Evidence of first integrated In-Situ/Cleanwater1 cross-sales rather than promises
What would challenge the forecast
No evidence of integrated customer wins
Current outcome
Not yet due
2 years
Review date
2028-11-15
Original forecast
Final EPA rule status and dated municipal procurement decisions
What to measure
Final EPA rule status and dated municipal procurement decisions
What must happen
Conditional review: Final EPA rule status and dated municipal procurement decisions
What would challenge the forecast
EPA extends compliance and municipalities delay orders
Current outcome
Not yet due
3 years
Review date
2029-11-15
Original forecast
Recurring consumable or service revenue and customer retention disclosed
What to measure
Recurring consumable or service revenue and customer retention disclosed
What must happen
Conditional review: Recurring consumable or service revenue and customer retention disclosed
What would challenge the forecast
Lower gross margin or elevated inventory
Current outcome
Not yet due
4 years
Review date
2030-11-15
Original forecast
Return on purchased businesses versus acquisition cost and goodwill
What to measure
Return on purchased businesses versus acquisition cost and goodwill
What must happen
Conditional review: Return on purchased businesses versus acquisition cost and goodwill
What would challenge the forecast
Cash returns on acquisitions below the cost of capital
Current outcome
Not yet due
5 years
Review date
2031-11-15
Original forecast
Per-share free cash flow after acquisitions, debt and buybacks
What to measure
Per-share free cash flow after acquisitions, debt and buybacks
What must happen
Conditional review: Per-share free cash flow after acquisitions, debt and buybacks
What would challenge the forecast
Premium earnings valuation compresses despite stable results
Current outcome
Not yet due
Sources
Dated source
Source ID
VLTO-S1
Source link and publication date
Publisher: SEC / Veralto
Original language: English
Reading access: partial
Underlying origin: VLTO-S1
published date precision: day
retrieved date precision: day
Source publication date 2026-10-29
Source retrieval date 2026-11-15
What this source supports
Q3 2026 earnings exhibit
Source ID
VLTO-S2
Source link and publication date
Publisher: SEC / Veralto
Original language: English
Reading access: partial
Underlying origin: VLTO-S2
published date precision: day
retrieved date precision: day
Source publication date 2026-10-30
Source retrieval date 2026-11-15
What this source supports
Q3 2026 Form10Q
Source ID
VLTO-S3
Source link and publication date
Publisher: SEC / Veralto
Original language: English
Reading access: partial
Underlying origin: VLTO-S3
published date precision: day
retrieved date precision: day
Source publication date 2026-07-29
Source retrieval date 2026-11-15
What this source supports
Q2 2026 Form10Q
Source ID
VLTO-S4
Source link and publication date
Publisher: US EPA
Original language: English
Reading access: partial
Underlying origin: VLTO-S4
published date precision: day
retrieved date precision: day
Source publication date 2026-05-18
Source retrieval date 2026-11-15
What this source supports
Proposed PFOA/PFOS extension
Source ID
VLTO-S5
Source link and publication date
Publisher: US EPA
Original language: English
Reading access: partial
Underlying origin: VLTO-S5
published date precision: day
retrieved date precision: day
Source publication date 2026-05-18
Source retrieval date 2026-11-15
What this source supports
Proposed PFAS rescission
Source ID
VLTO-S6
Source link and publication date
Publisher: US EPA
Original language: English
Reading access: partial
Underlying origin: VLTO-S6
published date precision: day
retrieved date precision: day
Source publication date 2026-07-01
Source retrieval date 2026-11-15
What this source supports
EPA context page last updated 1 July 2026; update date is not a new rule enactment.
Source ID
VLTO-S7
Source link and publication date
Publisher: Stock Analysis
Original language: English
Reading access: partial
Underlying origin: VLTO-S7
published date precision: day
retrieved date precision: day
Source publication date 2026-11-13
Source retrieval date 2026-11-15
What this source supports
Historical closing price
Source ID
VLTO-S8
Source link and publication date
Publisher: Stock Analysis
Original language: English
Reading access: partial
Underlying origin: VLTO-S8
published date precision: day
retrieved date precision: day
Source publication date 2026-11-13
Source retrieval date 2026-11-15
What this source supports
Market valuation overview
Source ID
VLTO-S9
Source link and publication date
Publisher: SEC / Veralto
Original language: English
Reading access: partial
Underlying origin: VLTO-S9
published date precision: day
retrieved date precision: day
Source publication date 2026-10-30
Source retrieval date 2026-11-15
What this source supports
Cleanwater1 subsequent event
Source limits
All eight original links reopened. SEC and company material are issuer disclosures, not independent proof of future returns. EPA policy pages still describe proposals. Stock Analysis price/valuation secondary. Added sensitivity assumptions are not predictions. Source metadata: Q3 10-Q SEC filing date30October2026 (accepted29October18:34:15); Q2 filing29July2026; EPA index last updated1July2026; Cleanwater1 note shares Q3 filing date. Period ends and acquisition date are distinct.